Arrowhead Pharmaceuticals, Inc. (ARWR)

NASDAQ: ARWR · Real-Time Price · USD

88.33

+0.68 (0.78%)

At close: Aug 10, 2026, 4:00 PM EDT

88.48

+0.15 (0.17%)

After-hours: Aug 10, 2026, 7:34 PM EDT

Arrowhead Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Revenue	669.5	829.45	3.55	240.74	243.23	138.29
Revenue Growth	16.84%	23258.15%	-98.52%	-1.03%	75.89%	57.16%
Gross Profit	669.5	829.45	3.55	240.74	243.23	138.29
Selling, General & Admin	172.57	123.94	98.76	92.55	124.43	80.98
Research & Development	723.37	607.16	505.87	353.19	297.31	206.34
Total Operating Expenses	895.93	731.1	604.63	445.74	421.74	287.32
Operating Income	-226.44	98.35	-601.08	-205	-178.51	-149.04
Interest Income	52.55	37.29	22.72	15.3	5.03	6.12
Interest Expense	-92.61	-89.36	-32.35	-18.33	-	-
Other Non-Operating Income (Expense)	14.42	5.26	-1.75	1.54	0.77	2.07
Total Non-Operating Income (Expense)	-25.64	-46.81	-11.38	-1.49	5.8	8.19
Pretax Income	-252.08	51.53	-612.46	-206.49	-172.71	-140.85
Provision for Income Taxes	20.05	21.42	-2.77	2.78	3.79	0
Net Income	-272.13	30.11	-609.69	-209.28	-176.49	-140.85
Minority Interest in Earnings	47.83	31.75	-10.2	-4	-0.43	-
Net Income to Common	-319.95	-1.63	-599.49	-205.28	-176.06	-140.85
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	140	134	120	107	105	104
Shares Outstanding (Diluted)	140	134	120	107	105	104
Shares Change	7.41%	11.67%	12.21%	1.26%	1.62%	3.00%
EPS (Basic)	-2.25	-0.01	-5.00	-1.92	-1.67	-1.36
EPS (Diluted)	-2.25	-0.01	-5.00	-1.92	-1.67	-1.36
EPS Growth	-	-	-	-	-	-
Free Cash Flow	-75.11	156.89	-604.32	-330.63	-188.91	147.75
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Per Share	-0.54	1.17	-5.05	-3.10	-1.79	1.42
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-33.82%	11.86%	-16927.10%	-85.16%	-73.39%	-107.77%
Profit Margin	-40.65%	3.63%	-17169.60%	-86.93%	-72.56%	-101.85%
FCF Margin	-11.22%	18.91%	-17018.30%	-137.34%	-77.67%	106.84%
EBITDA	-194.25	122.27	-582.49	-192.51	-168.09	-140.77
EBITDA Margin	-29.01%	14.74%	-16403.40%	-79.97%	-69.11%	-101.79%
EBIT	-226.44	98.35	-601.08	-205	-178.51	-149.04
EBIT Margin	-33.82%	11.86%	-16927.10%	-85.16%	-73.39%	-107.77%
Effective Tax Rate	-7.95%	41.56%	0.45%	-1.35%	-2.19%	-0.00%

SEC Filings: 10-K · 10-Q